Aplidin increases sensitivity to treatment in leukemia and lymphoma cells.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D047630:Depsipeptides; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D010456:Peptides, Cyclic / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D047630:Depsipeptides; D010456:Peptides, Cyclic; C098980:plitidepsin